Gilead Sciences Inc (GILD)
91.41
-0.47
(-0.51%)
USD |
NASDAQ |
Jan 03, 16:00
91.36
-0.05
(-0.05%)
After-Hours: 04:08
Gilead Sciences Research and Development Expense (TTM): 8.104B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
Pfizer Inc | 10.60B |
AbbVie Inc | 8.722B |
Eli Lilly and Co | 10.53B |
Merck & Co Inc | 22.98B |
Moderna Inc | 4.827B |